Platelet-Activating Factor: Pathophysiological Changes and Therapeutic Implications in Sepsis

This publication has 69 references indexed in Scilit:

• Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
  Chest, 1992
• Studies on the mechanism of platelet-activating factor production in GM-CSF primed neutrophils: Involvement of protein synthesis and phospholipase A2 activation
  Biochemical and Biophysical Research Communications, 1990
• GM-CSF: Receptor structure and transmembrane signaling
  The International Journal of Cell Cloning, 1990
• Inhibition of antigen-induced lung anaphylaxis in the guinea-pig by BN 52021 a new specific paf-acether receptor antagonist isolated from Ginkgo biloba
  Inflammation Research, 1986
• In vivo inhibition of plasma protein leakage andSalmonella enteritidis—induced mortality in the rat by a specific paf-acether antagonist: BN 52021
  Inflammation Research, 1986
• Association of Platelet-Activating Factor with Primary Acquired Cold Urticaria
  New England Journal of Medicine, 1985
• Effects of 1Oalkyl2acetylglycero3phosphocholine (platelet activating factor) on cardiac function in perfused guinea-pig heart
  Life Sciences, 1985
• Release of platelet-activating factor, slow-reacting substance, and vasoactive amines from isolated rat kidneys
  Kidney International, 1984
• Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxia
  Biochemical and Biophysical Research Communications, 1984
• CV-3988 - A specific antagonist of platelet activating factor (PAF)
  Life Sciences, 1983